Related Experiment Video
Updated: Aug 18, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas
Akiyoshi Ogino1, Atsuo Yoshino, Yoichi Katayama
1Department of Neurological Surgery, Nihon University School of Medicine, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. ayoshino@med.nihon-u.ac.jp
Abstract:
Pituitary adenomas are common benign intracranial neoplasms. However, their tumorigenesis is not yet clearly defined. Inactivation of genes involved in the negative cell-cycle regulatory p15(INK4b) - p16(INK4a) -cyclin D/CDK4-RB1-mediated pathway (RB1 pathway) is one of the most common and important mechanisms in the growth advantage of tumor cells. Recently, much attention has been focused on the importance of alternative mechanisms of gene inactivation, particularly promoter hypermethylation in the transcriptional silencing of such tumor-suppressor genes. Based on the rare occurrence of inactivation by gene mutations and deletions of the RB1 pathway in pituitary adenomas, we investigated the deregulation of the RB1 pathway in 42 sporadic human pituitary adenomas, especially focusing on the methylation status of this pathway as determined by a methylation-specific polymerase chain reaction assay. Homozygous deletion of the p15(INK4b) or p16(INK4a) gene was detected in one adenoma each. Amplification of the CDK4 gene was not apparent in any of the pituitary adenomas presently examined. Promoter hypermethylation of the p15(INK4b), p16(INK4a), and RB1 genes was detected in 15 (35.7%), 30 (71.4%), and 12 (28.6%) of the adenomas, respectively. Promoter hypermethylation of the p15(INK4b) gene coincided with p16(INK4a) alteration and/or RB1 methylation, whereas p16(INK4a) and RB1 methylations tended to be mutually exclusive (p = 0.019). Thus, the vast majority of the adenomas (38 of 42, 90.5%) displayed alterations of the RB1 pathway. None of the clinicopathologic features, including the proliferation cell index, was significantly correlated with any particular methylation status. Our results suggest that inactivation of the RB1 pathway may play a causal role in pituitary tumorigenesis, with hypermethylation of the p16(INK4a) gene being the most common deregulation, and further provide evidence that RB1 and p16(INK4a) methylations tend to be mutually exclusive but occasionally coincide with p15(INK4b) methylation.
Insights
Pituitary adenoma growth may be driven by alterations in the RB1 pathway, with gene promoter hypermethylation being the most common cause. Most adenomas showed RB1 pathway deregulation, particularly p16(INK4a) gene hypermethylation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pituitary adenomas are common brain tumors, but their development mechanisms are unclear.
- The RB1 pathway is crucial for cell cycle regulation and tumor suppression.
- Gene promoter hypermethylation is an emerging mechanism for silencing tumor suppressor genes.
Purpose of the Study:
- To investigate RB1 pathway deregulation in sporadic pituitary adenomas.
- To determine the frequency and patterns of gene promoter hypermethylation in these tumors.
- To explore the role of RB1 pathway inactivation in pituitary tumorigenesis.
Main Methods:
- Analysis of 42 sporadic human pituitary adenomas.
- Methylation-specific polymerase chain reaction (PCR) assay to assess promoter methylation status of p15(INK4b), p16(INK4a), and RB1 genes.
- Investigation of gene deletions and amplifications within the RB1 pathway.
Main Results:
- The vast majority of pituitary adenomas (90.5%) exhibited alterations in the RB1 pathway.
- Promoter hypermethylation was the predominant mechanism, affecting p15(INK4b) (35.7%), p16(INK4a) (71.4%), and RB1 (28.6%) genes.
- Hypermethylation of p16(INK4a) was the most frequent deregulation observed.
- RB1 and p16(INK4a) methylations were often mutually exclusive, but could co-occur with p15(INK4b) methylation.
Conclusions:
- Inactivation of the RB1 pathway, primarily through promoter hypermethylation, plays a significant role in pituitary tumorigenesis.
- p16(INK4a) gene hypermethylation is the most common alteration contributing to pituitary adenoma development.
- The interplay between RB1, p16(INK4a), and p15(INK4b) methylation patterns provides insights into pituitary tumor formation.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
